Please assess the completion status of the following clinical trial:

Trial Title: Italian Platelet Technology Assessment Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. adults (\> 18 years)~2. a hematooncology diagnosis (includes patients newly diagnosed and previously diagnosed)~3. expected to require 2 or more PLT transfusions in 4 weeks~4. hospital admission (patients admitted to out-patient clinics will not be enrolled)~5. chemotherapy, related and matched unrelated donor (MUD)transplant recipients~6. recurrent auto-transplanted patients, requiring chemotherapy~7. negative pregnancy test in female patients less than 60 years old~Exclusion Criteria:~1. presence of HLA class I abs on admission with PRA \>20%~2. historical documented record of 2 or more 1 hour post-TX PLT corrected count increments \<5,000 per microliter~3. previously included in IPTAS~4. diagnosis of a solid tumor

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pathogen reduced platelets (Type: EXPERIMENTAL): Transfusion
- Standard platelets (Type: ACTIVE_COMPARATOR): Transfusion

Based on this trial design, predict the completion outcome and termination type (if applicable).